vTv Therapeutics
VTVT
VTVT
19 hedge funds and large institutions have $357K invested in vTv Therapeutics in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$35K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.14K |
| 4 |
BlackRock
New York
|
+$645 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$154 |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$162K |
| 2 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$74K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$53K |
| 4 |
Jane Street
New York
|
-$38K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$33.3K |
